Key result
The A allele of the SCN10A gene polymorphism rs6795970 was associated with a higher risk of cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy.
Why the study?
Does the A allele of the SCN10A gene polymorphism rs6795970 increase the risk of cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy?
Observational (n=149)
Blinded to genotype status
No
Does the A allele of the SCN10A gene polymorphism rs6795970 increase the risk of cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy?
The SCN10A gene polymorphism rs6795970 (A allele) is significantly associated with an increased risk of cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May aid conduction risk stratification in HCM; hypothesis-generating and requires prospective validation.
Arrhythmias are associated with reduced quality of life and poor prognosis in patients with hypertrophic cardiomyopathy (HCM). Recent genome-wide association studies revealed that a nonsynonymous single nucleotide polymorphism, rs6795970, in the SCN10A gene was associated with the PR interval. We examined whether the PR prolonging allele (A allele) in the SCN10A gene may be associated with cardiac conduction abnormalities in HCM patients.We genotyped the polymorphism in 149 HCM patients. Conduction abnormalities were defined as first-degree heart block, bundle-branch block, and bifascicular heart block. Patients were divided into two groups: group A consisted of 122 patients (82%) without a conduction abnormality; and group B consisted of 27 patients (18%) with one or more cardiac conduction abnormalities. The frequency distribution of the SCN10A genotypes (G/G, G/A, and A/A) among the patients with HCM was 71%, 26%, and 3%, respectively. A cardiac conduction abnormality was documented in 9% with G/G and 40% with G/A or A/A. There was a significant difference in the genotype distribution between the two groups (P = 0.0002). In the dominant A allele model, there was a significant difference in genotypes between the two groups (P < 0.0001). In addition, the A allele remained significant after adjusting for other covariates in a multivariate model (odds ratio = 6.30 [95% confidence interval: 2.24 to 19.09], P = 0.0005).The rs6795970 in the SCN10A gene, which is reported to carry a high risk of heart block, might be associated with cardiac conduction abnormalities in HCM patients.
No takes yet. Share an insight, caveat, or question.
Iio et al. (2015) conducted an observational in Hypertrophic Cardiomyopathy (n=149). SCN10A gene polymorphism rs6795970 (A allele) vs. G/G genotype (non-carriers of A allele) was evaluated on Cardiac conduction abnormalities (first-degree heart block, bundle-branch block, and bifascicular heart block) (OR 6.30, 95% CI 2.24 to 19.09, p=0.0005). The A allele of the SCN10A gene polymorphism rs6795970 was associated with a higher risk of cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: